This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Phase I Clinical Trial

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Phase I Clinical Trial Means in Everyday Medical Language

A Phase I Clinical Trial is the first time a new treatment is tested in people after it has been studied in laboratory and animal tests. The main purpose is to find out if the treatment is safe and to learn about possible side effects. Doctors also try to determine the best dose and how often the treatment should be given. Sometimes they study different ways to give the treatment, such as by mouth, injection, or infusion into a vein. These trials usually involve a small number of patients, often those who have not had success with other treatments. Occasionally, healthy volunteers may take part.

Why Phase I Clinical Trials Matter in Cancer Care

Phase I trials are important because they help doctors understand how a new treatment behaves in the human body. This information is needed before testing the treatment in larger groups to see if it works against cancer. For patients with cancers that have not responded to standard therapies, phase I trials may offer access to new options. However, these trials focus on safety and dosing, not on proving effectiveness. They are a cautious first step in developing new cancer treatments.

What Patients Might See or Hear About Phase I Clinical Trials

Patients may hear about phase I trials when discussing treatment options, especially if standard treatments have not worked. Sometimes a tumor may be tested to see if it has specific proteins or molecular targets that a new treatment might attack. If so, a phase I trial might be considered. Patients might also come across terms like "phase I clinical trial" or "phase 1 clinical trial," which mean the same thing. It’s important to ask your healthcare team what a phase I trial means for your specific situation and whether it is a safe and appropriate choice.

Where the Term Might Appear

The term "phase I clinical trial" can appear in medical records, treatment plans, clinical trial listings, or research articles. It may also be mentioned during discussions about experimental treatments or new drugs being studied. For example, some phase I trials test drugs that target specific molecules in cancer cells, known as molecular targets. Understanding the context helps patients and caregivers know what to expect.

What the Term Does Not Automatically Mean

Seeing the term "phase I clinical trial" does not mean the treatment is proven to work or is a standard therapy. It also does not mean the treatment is free of risks or side effects. Phase I trials are primarily about safety and finding the right dose, not about curing cancer. Patients should not assume that participation guarantees benefit or that the treatment is approved for general use.

How Phase I Trials Connect to Related Terms

Phase I Clinical Trials often include dose-escalation studies, where the treatment dose is gradually increased to find the highest dose that does not cause harmful side effects. They may also be called First-In-Human (FIH) studies, meaning the treatment is being tested in people for the very first time after lab and animal studies. These terms can appear interchangeably, so it helps to ask your care team for clarification.

Common Questions to Ask Your Care Team

If a phase I clinical trial is mentioned, it’s helpful to ask your healthcare provider questions like: What is the goal of this trial? What are the possible risks and side effects? How might this trial affect my current treatment plan? Is this trial a suitable option for me? Your care team can explain how the study fits into your overall care and what to expect.

Understanding the Term in Context and Next Steps

Seeing the term "phase I clinical trial" is just one piece of information. It’s important to understand it in the full context of your diagnosis, treatment options, and health status. This explanation is for education only and does not decide what is safe or appropriate for any individual. If you see this term in your medical records or hear it from your care team, the best next step is to ask them directly what it means for you. They can provide personalized information and help you understand your options and what to expect.

Sources

Public source information used for this glossary entry includes: